Robert E. Wanerman, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in Modern Healthcare, in “Doctors Argue Leadless Pacemakers Deserve Broader Medicare Coverage,” by Virgil Dickson.
Following is an excerpt:
However, the CMS tends to be cautious in coverage decisions “until it is satisfied that the quantity and quality of data justify an additional treatment for a chronic condition,” said Robert Wanerman, an attorney at Epstein Becker Green and former assistant counsel at HHS.